Effect of the intake of Omega-7 vs. placebo on the components of the lipid profile in patients with Metabolic Syndrome

During this week I finally concluded with my thesis, finding some very interesting results, so I'd like to talk a little about it.

Nowadays a huge number of scientific evidence is proving the benefits obtained on the control of blood lipids and cardiovascular diseases by the consumption Omega-3, but we don't have enough knowledge about the impact that could have other "healthy" fatty acids like Omega-7. 

In the above highlights the importance of analyzing the effect of Omega-7. Therefore we make a double-blind clinical trial, that included 60 patients from the Health Center East Zone in the state of Colima diagnosed with metabolic syndrome. They were randomly divided in two groups and subjected to a treatment protocol with Omega-7 or placebo. The protocol was carried out for a month and the lipid profile was evaluated at the beginning and at the end of the intervention.

Finding at the end of the study than the group that received Omega-7 showed a significant decrease in total cholesterol and c-no-HDL levels and a significant increase in levels of HDL-c. Anthropometric measurements showed a significant decrease in waist and hip in the same group.

Therefore we can consider the Omega-7 as part of the treatment of metabolic syndrome, because it acts on a par of the components of this syndrome.